login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
OCULAR THERAPEUTIX INC (OCUL) Stock News
USA
- NASDAQ:OCUL -
US67576A1007
-
Common Stock
11.66
USD
-0.16 (-1.35%)
Last: 10/31/2025, 8:05:24 PM
11.66
USD
0 (0%)
After Hours:
10/31/2025, 8:05:24 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OCUL Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Zacks Investment Research
Wall Street Analysts Believe Ocular Therapeutix (OCUL) Could Rally 82.93%: Here's is How to Trade
4 days ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
24 days ago - By: Benzinga
- Mentions:
BOKF
FLEX
FRPT
DHR
...
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
25 days ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
a month ago - By: Benzinga
Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts
3 months ago - By: The Motley Fool
- Mentions:
AMD
OCUL Sales Drop 18%
a month ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
a month ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint
2 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
3 months ago - By: Zacks Investment Research
- Mentions:
PSTV
Ocular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates
3 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business Highlights
3 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
4 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
5 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
6 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
6 months ago - By: Zacks Investment Research
- Mentions:
ESPR
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
6 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
6 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
7 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Ocular Therapeutix, Inc.
Ocular Therapeutix™ to Participate in Two Investor Conferences in April
Please enable JavaScript to continue using this application.